- TV Footage
- Integrated Annual Reports
- Quarterly Reports
- Bayer Magazine
- BEENOW Magazine
- Farming’s Future Magazine
- research Magazine
- technology solutions Magazine
- From Molecules to Medicine
- From Molecules to Veterinary Medicines Brochure
- Integrated Weed Management
- Names | Figures | Facts
- Transfers of Value to Physicians Brochure
- Newsletter Overview
- Social Media
- Background Information
- Media Contact
Berlin, September 26, 2017 – The technical term in social psychology is cognitive dissonance. It refers to situations where people act against their better knowledge – by smoking, for example. Or by not using contraceptives even though they don't want to become pregnant. What causes such behavior? What role is played by the way in which knowledge is passed on?
In a new global study supported by Bayer, GFK Healthcare polled around 3,000 adolescents on their attitudes toward sexuality and contraception. The results are both encouraging and alarming at the same time. On the one hand they show evidence of improved access to information worldwide. But they also indicate that the number of teenage pregnancies remains alarmingly high.
According to WHO 41% of 208 million pregnancies worldwide are unplanned. 11% of all births are given by young women between the ages of 15 and 19. That's about 16 million teenage pregnancies a year. In the 'Youth and Contraception' study, an alarming 25.1% of respondents stated that they were so unlikely to become pregnant that they didn't need to use any method of contraception.
Much in the answers seems contradictory. On the one hand, the respondents agreed across all nationalities that the issue should be less of a taboo; yet surprisingly they also said they were able to talk about it with their partner without embarrassment. According to the study, in many countries schools and teachers are still the first to address the topic of sexuality and sex education. At the same time, the adolescents say they are not satisfied with this kind of sexuality education and prefer to get their information on the internet.
A cross-generation discussion seems to be difficult – regardless of people's respective culture and life circumstances. So successful sexuality education evidently requires not only the transfer of knowledge as such, but also an opportunity to ask questions and exchange experience.
These results confirm the importance of the World Contraception Day (WCD): This campaign consists of many projects throughout the whole year and culminates at September 26 to generate maximum publicity.The expanding use of digital channels and social-media activities offer young people an opportunity to meet and exchange information online without revealing their name and face. The subject of contraception is also shared and distributed by 'WCD ambassadors', who discuss their views worldwide – not in a patronizing way, but as conversations between equals.
"World Contraception Day has taught us that passing on knowledge not only takes time, but that the campaign itself also needs to keep on learning," Dr Michael Devoy, Chief Medical Officer, Bayer AG, said. "The campaign promotes an open dialogue and reacts with friendly, partnership-based expertise. Every adolescent who is well-informed and assumes self-determined responsibility for his or her family planning is a role model for others. The campaign gives these role models a platform."
At the same time, the campaign also targets parents and teachers, healthcare providers and, last but not least, governments and decision-makers, encouraging them to also promote the subject at the political level. The number of international partners in the WCD Coalition has risen to an impressive 14 since its launch. Bayer was there from the start.
Sexuality education and contraception belong together. Self-determined family planning with unrestricted access to contraceptives, and knowing how to protect yourself from sexually-transmitted diseases, are essential if we are to move toward a world in which every pregnancy is a wanted pregnancy.
About the study
The study on 'Youth and Contraception' examines the attitudes of young people aged between 13 and 25 years to sexuality and contraception. GfK Health surveyed a total of 3,013 young men and women from 15 countries in Europe, Asia, the Pacific region, as well as Latin and North America. The answers given to 9 questions and 11 statements reflect what young people think about this issue and indicate what still needs to be done to help preventing unplanned pregnancies. The study's findings can be found on the World Contraception Day website (in English only): https://www.your-life.com/
Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2016, the Group employed around 115,200 people and had sales of EUR 46.8 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.7 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com.
Follow us on Facebook: http://www.facebook.com/pharma.bayer
Follow us on Twitter: https://twitter.com/BayerPharma
Find more information at www.bayerpharma.com.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.